Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 306Lymphoma, Non-Hodgkin 227Lymphoma, Large B-Cell, Diffuse 220Lymphoma, Follicular 201Leukemia, Lymphocytic, Chronic, B-Cell 168Lymphoma, B-Cell 147Recurrence 124Burkitt Lymphoma 117Lymphoma, Mantle-Cell 112Leukemia, Myeloid, Acute 106Leukemia 103Hodgkin Disease 102Multiple Myeloma 95Lymphoma, B-Cell, Marginal Zone 87Neoplasms 80Myelodysplastic Syndromes 69Lymphoma, T-Cell, Peripheral 62Hematologic Neoplasms 61Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58Lymphoma, T-Cell 52Lymphoma, T-Cell, Cutaneous 44Waldenstrom Macroglobulinemia 41Leukemia, Biphenotypic, Acute 35Mycosis Fungoides 31Lymphoproliferative Disorders 30Leukemia, B-Cell 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Breast Neoplasms 28Myeloproliferative Disorders 26

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Chromosome Aberrations × Lymphoid × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡